Zobrazeno 1 - 10 of 11 pro vyhledávání: '"ERIN OH"'
1
130-LB: Linagliptin vs. Sitagliptin for Type 2 Diabetes Inpatient Glycemic Management and Cardiovascular Outcomes—Is There a Difference between DPP-4 Inhibitors?
Autor: SAMI BARAKAT, HELEN A. HABIB, CATHERINE CHUN, ERIN OH
Publikováno v: Diabetes. 71
Background: Oral DPP-4 inhibitors provide adjunctive therapy to insulin in hospitalized patients with blood glucose (BG) < 400 mg/dL. Results from trials comparing sitagliptin or linagliptin to basal-bolus insulin showed mixed results, with no head-t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2392bc7aa49287e6bc7e801c88693cc5
https://doi.org/10.2337/db22-130-lb
Zobrazit plný text záznamu
3
846-P: Basal Insulin Management in Inpatients Who Are Not Eating: Is There a Difference between Medical and Surgical Patients?
Autor: John Paul Sacdal, Erin Oh, Helen Habib, Eunah Cheon
Publikováno v: Diabetes. 70
Background: Guidelines from the 2021 American Diabetes Association recommend basal or basal plus correctional insulin dosing for non-critically ill hospitalized patients with poor oral intake or are nil per os (NPO). The recommended adjustment is 75-
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e627f890c9673f3bd91595e239031cf5
https://doi.org/10.2337/db21-846-p
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje